背景:Tungiasis是由雌性跳蚤Tungapenetrans引起的皮肤寄生虫病。双组分二甲酮(NYDA)是世界卫生组织推荐的唯一治疗方法;但是,这种外用药物在肯尼亚没有。在肯尼亚西部,碳酸钠常用于治疗苔藓病。这项研究通过比较霍马湾县的碳酸钠和NYDA治疗方法,评估了7天的治愈率,肯尼亚。
结果:这是一个随机的,观察者失明,平行治疗队列试验。对23名符合条件的126例跳蚤感染儿童进行了匹配和随机分组。所有参与者都接受了两种治疗,每只脚都有一次治疗。我们记录了所有健康状况/信息,包括炎症评分和不良事件。在第3天、第5天和第7天使用数字显微镜进行观察,以基于生存力体征确认死亡的或活的跳蚤。对23名3-13岁儿童进行了分析。NYDA治疗后第7天死亡跳蚤的比例高于5%碳酸钠治疗后(87%对64%,分别,P=0.01)NYDA。两种治疗的中位生存期均为5天;NYDA的跳蚤无活力率明显高于5%碳酸钠(P<0.01)。两种治疗之间的炎症评分或疼痛/瘙痒没有显着差异。在最后一天,14名儿童表示他们在未来的治疗中更喜欢NYDA,而9名儿童更喜欢5%碳酸钠溶液。
结论:NYDA比5%碳酸钠治疗的效果更明显。两种治疗方法都是安全的,但孩子们更喜欢NYDA。未来有更多参与者的研究和延长的观察期是必要的,以证实我们的发现。研究结果表明,NYDA应在tungiasis流行地区提供更多。
背景:UMIN-CTR;UMIN000044320。
BACKGROUND: Tungiasis is a cutaneous parasitosis caused by the female flea Tunga penetrans. Two-component dimeticone (NYDA) is the only treatment for tungiasis recommended by the World Health Organization; however, this topical drug is not available in Kenya. In Western Kenya, sodium carbonate is commonly used in the treatment of tungiasis. This study evaluated the 7-day cure rates for tungiasis by comparing sodium carbonate and NYDA treatments in Homa Bay County, Kenya.
RESULTS: This was a randomized, observer-blinded, parallel-treatment cohort trial. Twenty-three eligible children with 126 flea infections were matched and randomized. All participants received both treatments, with one treatment on each foot. We recorded all health conditions/information, including inflammation scores and adverse events. Observations were performed on days 3, 5, and 7 using a digital microscope to confirm dead or live fleas based on the viability signs. Twenty-three children aged 3-13 years were analyzed. The proportion of dead fleas on day 7 was higher after NYDA treatment than after 5% sodium carbonate treatment (87% versus 64%, respectively, P = 0.01) NYDA. Median survival was 5 days for both treatments; NYDA had significantly higher trend of flea non-viability rate than 5% sodium carbonate (P<0.01). There were no significant differences in the inflammation score or pain/itchiness between the two treatments. On the last day, 14 children indicated their preference for NYDA in future treatment of tungiasis, whereas nine children preferred the 5% sodium carbonate solution.
CONCLUSIONS: NYDA was significantly more effective than 5% sodium carbonate for tungiasis treatment. Both treatments were safe but the children preferred NYDA more. Future studies with more participants and an extended observation period are warranted to confirm our findings. The findings suggest that NYDA should be made more available in tungiasis endemic area.
BACKGROUND: UMIN-CTR; UMIN 000044320.